Company profile

Molbio Diagnostics

Molbio Diagnostics, founded in 2000, became a unicorn in September 2022 with a $1.6 billion valuation. The company has raised $124 million to date from investors including Temasek and Motilal Oswal Private Equity. Headquartered in Salcete, Goa, India, Molbio Diagnostics provides point-of-care molecular diagnostic solutions including cartridge-based sample prep, portable x-ray systems, AI thermal scanning, and real-time PCR analyzers. Serving hospitals and laboratories, the platform enables rapid, accurate infectious disease detection. With strong funding and innovative diagnostics, Molbio Diagnostics is positioned to scale healthcare access and molecular testing worldwide.

Back to profiles

Quick facts

Total funding: $1.6 billion
Valuation: $1.6 billion
Founded: 2000

Notable investors

Temasek
Motilal Oswal Private Equity

Reach buyers like Molbio Diagnostics on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Molbio Diagnostics
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Molbio Diagnostics.

The 14-day trial ships every feature, no card required.

Start free →